Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
48 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Baldwin
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Kaiser Permanente-Harbor City
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Kaiser Permanente-Sunset
Los Angeles, California, United States
- Kaiser Permanente-West Los Angeles (cadillac)
Los Angeles, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Kaiser Permanente-Panorama City
Panorama City, California, United States
- Kaiser Permanente-Riverside
Riverside, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- Kaiser Permanente-Sacramento
Sacramento, California, United States
- Kaiser Permanente-Medical Group
San Diego, California, United States
- Kaiser Permanente-Zion
San Diego, California, United States
- Kaiser Permanente-San Francisco
San Francisco, California, United States
- Kaiser Permanente-San Jose
San Jose, California, United States
- Kaiser Permanente-San Leandro
San Leandro, California, United States
- Kaiser Permanente-San Marcos
San Marcos, California, United States
- Kaiser Permanente Medical Center Santa Clara
Santa Clara, California, United States
- Kaiser Permanente-South San Francisco
South San Francisco, California, United States
- Kaiser Permanente-Vallejo
Vallejo, California, United States
- Kaiser Permanente-Walnut Creek
Walnut Creek, California, United States
- Kaiser Permanente-Woodland Hills
Woodland Hills, California, United States
- Uf Health Davis Cancer Pavilion and Shands Medical Plaza
Gainesville, Florida, United States
- University of Florida
Gainesville, Florida, United States
- Cancer Care Specialists of Central Il-Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Crosslands Cancer Center
Effingham, Illinois, United States
- Cancer Care Specialists of Central Il-Swansea
Swansea, Illinois, United States
- Trinity Health Michigan
Ann Arbor, Michigan, United States
- Bronson Battle Creek
Battle Creek, Michigan, United States
- St. Joseph Mercy Brighton
Brighton, Michigan, United States
- St. Joseph Mercy Canton
Canton, Michigan, United States
- St. Joseph Mercy Chelsea
Chelsea, Michigan, United States
- Cancer Research Consortium of West Michigan
Grand Rapids, Michigan, United States
- Spectrum Health Butterworth
Grand Rapids, Michigan, United States
- St. Mary Mercy Hospital
Livonia, Michigan, United States
- Mercy Health Mercy Campus
Muskegon, Michigan, United States
- St. Mary'S of Michigan
Saginaw, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 May 2018
- Primary completion
- 30 Sept 2021
- Completion
- 30 Sept 2022
- Last update posted
- 31 Mar 2022
- Registered enrollment
- 35
- Registry id
- NCT03457896
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.